Home Sleep Therapy for Older Adults With MCI
Part of paid clinical trials in Winston-Salem, North Carolina.
- Sponsor
- Brain Electrophysiology Laboratory Company
- Study ID
- NCT05771844
- Status
- Recruiting
Conditions
- Machine Learning
- Memory
- Mild Cognitive Impairment
- Sleep
- Transcranial Electrical Stimulation
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 85 Years
- Healthy Volunteers
- Accepted
Interventions
- Transcranial Electrical Stimulation — DEVICEOscillating electrical current
Study Details
The goal of this clinical trial is to learn about the ability of non-invasive brain stimulation during sleep to enhance people's deep sleep and its potential benefit on memory in people with mild cognitive impairment via home use sleep therapy device (SleepWISP) as well as learn about biomarkers associated with Alzheimer disease (AD). The clinical trial aims to answer the following main questions: 1. Whether the non-invasive transcranial electrical stimulation (TES) delivered by SleepWISP could provide short-term enhancement of deep sleep in a single night in the target population. 2. Whether TES delivered by SleepWISP could enhance deep sleep over multiple nights in the target population. 3. Whether enhance on deep sleep could improve memory performance in the target population. Participants will be asked to wear non-invasive and painless devices that record their brain activity during sleep along with an actigraphy watch that measures their movement throughout the day. In addition, blood samples or nasal swab assays will be collected from participants multiple times during the study.
Key Dates
- Start date
- Feb 8, 2023
- Status verified
- Feb 2025
- Primary completion
- Jun 1, 2026
- Completion
- Jun 1, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Deep Sleep Enhancement with TESTranscranial Electrical Stimulation, 0.5 Hz sine wave, 0.5 mA, between frontal (frontopolar and inferior lateral frontal) and posterior (mastoid and occipital) electrodes.
Primary Outcome Measure
Device Usability [ Time Frame: Collected each day they use the Sleep WISP system, for three sessions over 10 days during Phase I of the study. ]
Central Contacts
- Don M Tucker, PhD541-653-8266
- Phan Luu, PhD541-653-9797
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wake Forest University | Winston-Salem | North Carolina | 27109 | Ruth Benca, PhD Caitlin Carroll, PhD |
| Brain Electrophysiology Laboratory Company | Eugene | Oregon | 97405 |
Find similar trials in Winston-Salem, NC
Related Studies
- Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's DiseaseEnrolling By Invitation · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Wake Forest Alzheimer's Disease Clinical CoreRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Retinal Imaging in Neurodegenerative DiseaseRecruiting · Duke University · Durham, North Carolina
- Brain Energy for Amyloid Transformation in Alzheimer's Disease StudyRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina